SUCCESS STORIES
-
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success
8/15/2023
A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.
-
Pharmaceutical Company Gets Unified Decentralized Platform
2/28/2023
Unearth how this global eClinical provider delivered a decentralized platform including eSource/ePRO for direct-data-entry, randomization, eConsent, telehealth, remote monitoring, and data management.
-
Global Phase 3 Study Rescued In Record Time
2/28/2023
DSG was selected as the preferred vendor for providing global support and enhanced data quality. Find out how the company was able to dramatically improve database build and study conduct.
-
CAR T Study For Blockbuster Drug Granted Therapy Designation
2/28/2023
Discover how a pharmaceutical sponsor received support for an EDC and IRT database build and got help with data management and biostatistics.
This website uses cookies to ensure you get the best experience on our website. Learn more